Aldevron Adds DasherGFP® mRNA to its Product Portfolio
February 12, 2020 10:30 ET
|
Aldevron
Fargo, N.D., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies for the biotech industry, announced...
Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results
February 10, 2020 16:05 ET
|
Fluidigm Corporation
Fourth quarter revenue of $32.4 million Full year 2019 revenue increased 4 percent to $117.2 million; full year mass cytometry revenue increased 23 percent Landmark Nature publication demonstrates...
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
September 09, 2019 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Gene Expression Market To Reach USD 6.27 Billion By 2026 | Reports And Data
June 05, 2019 11:54 ET
|
Reports And Data
The increasing availability of gene expression databases and a decrease in the cost of sequencing is fueling the growth of the market. Market Size – USD 3.30 Billion in 2018, Market Growth - CAGR of...
DNA and Gene Chip Market To Reach USD 11.25 Billion by 2026 | Reports And Data
May 22, 2019 12:52 ET
|
Reports And Data
High prevalence of Cancer, technical knowledge about gene expression, need for sustainable agricultural yields, increasing strategic developments such as collaborative studies, favorable research...
Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD
September 07, 2018 07:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced an expanded Immuno-Oncology Gene Expression Workflow to...